BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

59.07

-1.25 (-2.07%)

At close: Mar 12, 2026, 4:00 PM EDT

58.53

-0.54 (-0.92%)

After-hours: Mar 12, 2026, 6:25 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
VOXZOGO Revenue	926.92M	735.09M
VOXZOGO Revenue Growth	26.10%	56.44%
VIMIZIM Revenue	792.05M	739.78M
VIMIZIM Revenue Growth	7.07%	5.53%
NAGLAZYME Revenue	485.40M	479.58M
NAGLAZYME Revenue Growth	1.21%	14.11%
PALYNZIQ Revenue	433.31M	355.05M
PALYNZIQ Revenue Growth	22.04%	16.82%
ALDURAZYME Revenue	208.51M	183.89M
ALDURAZYME Revenue Growth	13.39%	40.11%
BRINEURA Revenue	186.40M	169.08M
BRINEURA Revenue Growth	10.24%	4.44%
KUVAN Revenue	99.53M	120.90M
KUVAN Revenue Growth	-17.68%	-33.12%
ROCTAVIAN Revenue	35.64M	26.07M
ROCTAVIAN Revenue Growth	36.73%	647.09%
Total Net Product Revenue	3.17B	2.81B
Total Net Product Revenue Growth	12.75%	18.41%
Royalty and Other Revenue	53.49M	44.47M
Royalty and Other Revenue Growth	20.29%	-4.75%
Revenue (Total)	3.22B	2.85B
Revenue (Total) Growth	12.87%	17.97%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Royalty and Other Revenue	53.49M	44.47M
Royalty and Other Revenue Growth	20.29%	-4.75%
United States Revenue	1.10B	924.81M
United States Revenue Growth	19.48%	19.90%
Europe Revenue	874.33M	829.03M
Europe Revenue Growth	5.46%	23.86%
Latin America Revenue	435.48M	378.08M
Latin America Revenue Growth	15.18%	13.73%
Rest of World Revenue (Post-Q2 2024)	544.47M	493.63M
Rest of World Revenue (Post-Q2 2024) Growth	10.30%	5.43%
Revenue (Other)	208.51M	183.89M
Revenue (Total)	3.22B	2.85B
Revenue (Total) Growth	12.87%	17.97%

Updated Dec 31, 2025. Data Source: Fiscal.ai.